Inhalation

INH0220

Issue link: https://www.e-digitaleditions.com/i/1208415

Contents of this Issue

Navigation

Page 27 of 35

This section provides information that may be useful in research and development or manufacturing. Content is provided by the organizations listed. No endorsement or preference is intended. 26 February 2020 Inhalation Issue Focus This section of Inhalation provides information that may be useful in research and development or manufacturing. Content is provided by the companies listed. No product endorsement or preference is intended. Product develoPment/ contract testing A new paradigm in IVIVC studies Proveris ® Laboratories offers a new characterization technology to relate in vitro to in vivo performance. INVIDA™, our in vitro Inhaled Drug Analysis Plat- form, utilizes physiological models and human realistic breathing profiles to accurately measure aerosol disper- sion and regional deposition of inhaled drugs. Profiling studies can provide you the critical information needed to help understand the complex relationships of device, formulation and human usage—determining true product performance, which can accelerate your prod- uct development and market release. Proveris Scientific Corporation US: +1 508 460-8822 www.proveris.com Automatic sample recovery in under one hour Astech has introduced its new Xelox ® automated NGI Sample Preparation System. When you load up to five NGI cup trays and select your method from the intuitive touch screen interface, the Xelox system will automati- cally prepare and recover your samples, ready for HPLC analysis. Parallel processing of all five trays with Astech's powerful scheduling software gives you primary and duplicate samples in under one hour. Astech Projects UK: +44 1928 571797 www.astechprojects.co.uk A connected metered dose inhaler H&T Presspart and Cohero Health have developed a market-ready, fully embedded and connected metered dose inhaler; the eDMI. By tracking and recording data on the use of medications, and sharing it wirelessly with patients and physicians via a mobile or web app, the eMDI supports real-time monitoring of patients and provides customized reminders on medication use. e partnership combines Cohero Health's expertise in dig- ital innovation with H&T Presspart's 40 years' experi- ence in MDI design and component manufacture. Presspart Manufacturing, Ltd. UK: +44 1254 582233 www.presspart.com

Articles in this issue

Links on this page

view archives of Inhalation - INH0220